サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1442495

アルファアミラーゼの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 形態別、用途別、原料別、地域別

Alpha Amylase Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日: | 発行: Fairfield Market Research | ページ情報: 英文 300 Pages | 納期: 2～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
アルファアミラーゼの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 形態別、用途別、原料別、地域別
出版日: 2024年02月19日
発行: Fairfield Market Research
ページ情報: 英文 300 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のアルファアミラーゼの市場規模は、2023年の18億米ドルから、2031年末には25億米ドルに急増すると予測されています。

健康とウェルネスに関する消費者の意識の高まりは、食品の消費パターンに大きな変化をもたらしています。消費者の健康志向が高まるにつれて、健康と栄養に役立つ製品を好む傾向が強まっています。アルファアミラーゼは、消化器系の健康効果と免疫系のサポートで知られ、この動向に伴って需要が増加しています。同市場は、より健康的な食品を選択しようという消費者の意識の高まりから恩恵を受ける態勢を整えています。

製薬業界では、免疫系サポート、炎症管理、血糖値正常化など様々な健康上の利点があるため、アルファアミラーゼの需要が伸びています。消化を助け、エネルギーを供給することが科学的に証明されているアルファアミラーゼは、消化器系疾患への対処や健康全般のサポートを目的とした医薬品に幅広く応用されています。座りがちなライフスタイルや不健康な食生活が消化器系疾患の増加に寄与していることから、医薬品セクターはアルファアミラーゼ市場拡大の有望な道筋を示しています。

アルファアミラーゼの世界市場では欧州が圧倒的な強さを見せ、2023年には28.0%という最高の数量シェアとなりました。同地域の高度なバイオテクノロジー産業と広範なエンドユーザー基盤が市場のリーダーシップに寄与しており、継続的な成長と革新の舞台となっています。

南アジアでは、アルファアミラーゼ市場が2031年末までに大幅な成長を示すと予測されます。CAGRは9.4%と予測され、この地域は消費者の嗜好の進化と食品・医薬品分野の拡大に後押しされ、市場関係者にとって有利な機会をもたらします。

当レポートでは、世界のアルファアミラーゼ市場について調査し、市場の概要とともに、形態別、用途別、原料別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 生産高と貿易統計、2018年～2023年

第4章 価格分析、2018年～2023年

第5章 世界のアルファアミラーゼ市場の見通し、2018年～2031年

  • 世界のアルファアミラーゼ市場の見通し、形態別、金額（10億米ドル）、数量（個）、2018年～2031年
  • 世界のアルファアミラーゼ市場の見通し、用途別、金額（10億米ドル）、数量（個）、2018年～2031年
  • 世界のアルファアミラーゼ市場の見通し、原料別、金額（10億米ドル）、数量（個）、2018年～2031年
  • 世界のアルファアミラーゼ市場の見通し、地域別、金額（10億米ドル）、数量（個）、2018年～2031年

第6章 北米のアルファアミラーゼ市場の見通し、2018年～2031年

第7章 欧州のアルファアミラーゼ市場の見通し、2018年～2031年

第8章 アジア太平洋のアルファアミラーゼ市場の見通し、2018年～2031年

第9章 ラテンアメリカのアルファアミラーゼ市場の見通し、2018年～2031年

第10章 中東・アフリカのアルファアミラーゼ市場の見通し、2018年～2031年

第11章 競合情勢

  • エンドユーザー別と用途別のヒートマップ
  • 企業の市場シェア分析、2022年
  • 競合ダッシュボード
  • 企業プロファイル
    • Novozymes
    • Aumgene Biosciences
    • Lee BioSolutions
    • AB Enzymes
    • Infinita Biotech Private Limited
    • Jiangsu Boli Bioproducts Co., Ltd.
    • Actiza Pharmaceutical Private Limited
    • Brisk Bioscience.
    • Sisco Research Laboratories Pvt Ltd
    • Karyotica Biologicals
    • Biolaxi Corporation
    • Creative Enzymes
    • Rejoice Life Ingredients
    • Enzyme Bioscience Pvt. Ltd.
    • Sunson Industry Group Co., Ltd.

第12章 付録

目次

The global alpha amylase market is set to witness robust growth in the coming years, according to a comprehensive market analysis covering the period from 2024 to 2031. The market is anticipated to surge from US$ 1.8 billion in 2023 to a staggering US$ 2.5 billion by the end of 2031. The analysis, which delves into various aspects of the market landscape, sheds light on key trends, regional insights, category-wise outlook, and competitive dynamics shaping the alpha amylase industry.

Rising Consumer Awareness Regarding Health Beneficial Products

Increasing consumer awareness regarding health and wellness is driving significant shifts in food consumption patterns. As consumers become more health-conscious, there is a growing preference for products offering enhanced health and nutrition benefits. Alpha amylase, known for its digestive health benefits and immune system support, is witnessing increased demand in line with this trend. The market is poised to benefit from this heightened consumer consciousness towards healthier food choices.

Bio-preservation Trend Fuelling Alpha Amylase Demand in Food Industry

Bio-preservation, aimed at extending the shelf life of food products through natural means, is gaining traction among consumers seeking safer and fresher food options. With artificial preservatives falling out of favor, alpha amylase emerges as a crucial component in the bio-preservation process. Its ability to maintain food freshness while meeting safety standards aligns with consumer preferences for clean label, natural products, thus driving its demand across various food sectors including dairy, beverages, and bakery.

Increasing Demand of Alpha Amylase in Pharmaceutical Industry to Bolster Sales

The pharmaceutical industry is witnessing a growing demand for alpha amylase, attributed to its various health benefits including immune system support, inflammation management, and blood sugar normalization. Scientifically proven to aid digestion and provide energy, alpha amylase is finding extensive applications in medicines aimed at addressing digestive disorders and supporting overall health. With sedentary lifestyles and unhealthy dietary habits contributing to the rise in digestive issues, the pharmaceutical sector presents a promising avenue for alpha amylase market expansion.

High Cost of Alpha Amylase to Hamper Sales

Despite its promising prospects, the high cost associated with alpha amylase remains a significant challenge for market growth. The intricate production process and sensitivity to environmental factors contribute to its expensive nature, deterring potential customers. While advancements in production methods have opened new possibilities, the premium pricing of alpha amylase continues to pose hurdles in widespread adoption.

Country-wise Insights

Europe Dominates Global Alpha Amylase Market

Europe emerges as the dominant force in the global alpha amylase market, boasting the highest volume share of 28.0% in 2023. The region's advanced biotechnology industry and extensive end-user base contribute to its market leadership, setting the stage for continued growth and innovation.

South Asia Presents Promising Growth Opportunities

In South Asia, the alpha amylase market is forecasted to exhibit substantial growth by the end of 2031. With a projected CAGR of 9.4%, the region presents lucrative opportunities for market players, fueled by evolving consumer preferences and expanding food and pharmaceutical sectors.

Category-wise Insights

Bakery Segment to Witness Steady Growth

Within the food and beverage industry, the bakery segment stands out with a projected CAGR of 8.3%. Alpha amylase's ability to enhance shelf life and improve baking volume positions it as a valuable ingredient in bakery products, driving market growth. Additionally, the demand for alpha amylase in confectionary and bio-preservation applications is on the rise, further bolstering market prospects.

Powder Form Dominates Market Share

Among different forms of alpha amylase, powder holds the largest market share, accounting for 79.3% of the global market. Its easy availability and versatility make it a preferred choice for various applications, although liquid alpha amylase is also witnessing increasing demand owing to its diverse application possibilities.

Competitive Analysis

Leading players in the global alpha amylase market, including Novozymes, Lee BioSolution, and AB Enzymes, are focusing on product diversification and research and development initiatives to maintain their competitive edge. Strategic partnerships, acquisitions, and custom manufacturing services are key strategies employed by these players to expand their market presence and cater to evolving customer needs.

The market also sees active participation from companies such as Aumgene Biosciences, Jiangsu Boli Bioproducts Co., Ltd., Ottokemi, Lee Biosolutions, Inc., and Karyotica Biologicals Pvt. Ltd., each leveraging unique capabilities and strategies to capitalize on emerging opportunities and drive innovation within the industry.

Alpha Amylase Industry Research by Category

By Form:

  • Powder & Granules
  • Liquid

By Application:

  • Food & Beverage Industry
    • Confectionery
    • Bakery
    • Brewing
    • Other Processed Food
  • Pharmaceuticals
  • Animal Feed
  • Research
  • Detergent
  • Others

By Source:

  • Bacteria
  • Fungi
  • Plants & Animals

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Alpha Amylase Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Ankle Syndesmosis Treatment Devices Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Form, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Ankle Syndesmosis Treatment Devices Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Alpha Amylase Market Outlook, 2018 - 2031

  • 5.1. Global Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Powder & Granules
      • 5.1.1.2. Liquid
  • 5.2. Global Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Food & Beverage Industry
        • 5.2.1.1.1. Confectionery
        • 5.2.1.1.2. Bakery
        • 5.2.1.1.3. Brewing
        • 5.2.1.1.4. Other Processed Food
      • 5.2.1.2. Pharmaceuticals
      • 5.2.1.3. Animal Feed
      • 5.2.1.4. Research
      • 5.2.1.5. Detergent
      • 5.2.1.6. Others
  • 5.3. Global Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Bacteria
      • 5.3.1.2. Fungi
      • 5.3.1.3. Plants & Animals
  • 5.4. Global Alpha Amylase Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Alpha Amylase Market Outlook, 2018 - 2031

  • 6.1. North America Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Powder & Granules
      • 6.1.1.2. Liquid
  • 6.2. North America Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Food & Beverage Industry
        • 6.2.1.1.1. Confectionery
        • 6.2.1.1.2. Bakery
        • 6.2.1.1.3. Brewing
        • 6.2.1.1.4. Other Processed Food
      • 6.2.1.2. Pharmaceuticals
      • 6.2.1.3. Animal Feed
      • 6.2.1.4. Research
      • 6.2.1.5. Detergent
      • 6.2.1.6. Others
  • 6.3. North America Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Bacteria
      • 6.3.1.2. Fungi
      • 6.3.1.3. Plants & Animals
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.2. U.S. Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.3. U.S. Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.4. Canada Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.5. Canada Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.6. Canada Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Alpha Amylase Market Outlook, 2018 - 2031

  • 7.1. Europe Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Powder & Granules
      • 7.1.1.2. Liquid
  • 7.2. Europe Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Food & Beverage Industry
        • 7.2.1.1.1. Confectionery
        • 7.2.1.1.2. Bakery
        • 7.2.1.1.3. Brewing
        • 7.2.1.1.4. Other Processed Food
      • 7.2.1.2. Pharmaceuticals
      • 7.2.1.3. Animal Feed
      • 7.2.1.4. Research
      • 7.2.1.5. Detergent
      • 7.2.1.6. Others
  • 7.3. Europe Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Bacteria
      • 7.3.1.2. Fungi
      • 7.3.1.3. Plants & Animals
    • 7.3.2. Attractiveness Analysis
  • 7.4. Europe Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.2. Germany Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.3. Germany Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.4. U.K. Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.5. U.K. Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.6. U.K. Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.7. France Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.8. France Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.9. France Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.10. Italy Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.11. Italy Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.12. Italy Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.13. Turkey Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.14. Turkey Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.15. Turkey Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.16. Russia Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.17. Russia Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.18. Russia Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Alpha Amylase Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Powder & Granules
      • 8.1.1.2. Liquid
  • 8.2. Asia Pacific Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Food & Beverage Industry
        • 8.2.1.1.1. Confectionery
        • 8.2.1.1.2. Bakery
        • 8.2.1.1.3. Brewing
        • 8.2.1.1.4. Other Processed Food
      • 8.2.1.2. Pharmaceuticals
      • 8.2.1.3. Animal Feed
      • 8.2.1.4. Research
      • 8.2.1.5. Detergent
      • 8.2.1.6. Others
  • 8.3. Asia Pacific Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Bacteria
      • 8.3.1.2. Fungi
      • 8.3.1.3. Plants & Animals
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.2. China Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.3. China Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.4. Japan Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.5. Japan Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.6. Japan Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.7. South Korea Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.8. South Korea Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.9. South Korea Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.10. India Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.11. India Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.12. India Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Alpha Amylase Market Outlook, 2018 - 2031

  • 9.1. Latin America Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Powder & Granules
      • 9.1.1.2. Liquid
  • 9.2. Latin America Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.2.1.1. Food & Beverage Industry
        • 9.2.1.1.1. Confectionery
        • 9.2.1.1.2. Bakery
        • 9.2.1.1.3. Brewing
        • 9.2.1.1.4. Other Processed Food
      • 9.2.1.2. Pharmaceuticals
      • 9.2.1.3. Animal Feed
      • 9.2.1.4. Research
      • 9.2.1.5. Detergent
      • 9.2.1.6. Others
  • 9.3. Latin America Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Bacteria
      • 9.3.1.2. Fungi
      • 9.3.1.3. Plants & Animals
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.2. Brazil Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.3. Brazil Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.4. Mexico Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.5. Mexico Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.6. Mexico Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.7. Argentina Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.8. Argentina Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.9. Argentina Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Alpha Amylase Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Powder & Granules
      • 10.1.1.2. Liquid
  • 10.2. Middle East & Africa Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Food & Beverage Industry
        • 10.2.1.1.1. Confectionery
        • 10.2.1.1.2. Bakery
        • 10.2.1.1.3. Brewing
        • 10.2.1.1.4. Other Processed Food
      • 10.2.1.2. Pharmaceuticals
      • 10.2.1.3. Animal Feed
      • 10.2.1.4. Research
      • 10.2.1.5. Detergent
      • 10.2.1.6. Others
  • 10.3. Middle East & Africa Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Bacteria
      • 10.3.1.2. Fungi
      • 10.3.1.3. Plants & Animals
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.2. GCC Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.3. GCC Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.4. South Africa Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.5. South Africa Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.6. South Africa Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.7. Egypt Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.8. Egypt Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.9. Egypt Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.10. Nigeria Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.11. Nigeria Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.12. Nigeria Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Application Heatmap
  • 11.2. Company Market Share Analysis, 2022
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Novozymes
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Aumgene Biosciences
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Lee BioSolutions
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. AB Enzymes
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Infinita Biotech Private Limited
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Jiangsu Boli Bioproducts Co., Ltd.
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Actiza Pharmaceutical Private Limited
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Brisk Bioscience.
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Sisco Research Laboratories Pvt Ltd
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development
    • 11.4.10. Karyotica Biologicals
      • 11.4.10.1. Company Overview
      • 11.4.10.2. Product Portfolio
      • 11.4.10.3. Financial Overview
      • 11.4.10.4. Business Strategies and Development
    • 11.4.11. Biolaxi Corporation
      • 11.4.11.1. Company Overview
      • 11.4.11.2. Product Portfolio
      • 11.4.11.3. Financial Overview
      • 11.4.11.4. Business Strategies and Development
    • 11.4.12. Creative Enzymes
      • 11.4.12.1. Company Overview
      • 11.4.12.2. Product Portfolio
      • 11.4.12.3. Financial Overview
      • 11.4.12.4. Business Strategies and Development
    • 11.4.13. Rejoice Life Ingredients
      • 11.4.13.1. Company Overview
      • 11.4.13.2. Product Portfolio
      • 11.4.13.3. Financial Overview
      • 11.4.13.4. Business Strategies and Development
    • 11.4.14. Enzyme Bioscience Pvt. Ltd.
      • 11.4.14.1. Company Overview
      • 11.4.14.2. Product Portfolio
      • 11.4.14.3. Financial Overview
      • 11.4.14.4. Business Strategies and Development
    • 11.4.15. Sunson Industry Group Co., Ltd.
      • 11.4.15.1. Company Overview
      • 11.4.15.2. Product Portfolio
      • 11.4.15.3. Financial Overview
      • 11.4.15.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations